Supporting Innovative Ideas and Programs to Advance the Lysosomal Storage Disorder Community Worldwide
Genzyme is pleased to have completed the third annual Patient Advocacy Leadership Awards (PAL Awards) program for non-profit organizations that serve the lysosomal storage disorder (LSD) patient community. The PAL Awards program seeks to spark innovation in disease awareness programs and patient support initiatives around the world. Please visit this website for more information on next year’s PAL Awards program in the coming months.
As an independent voice in the lysosomal storage disease community, patient organizations play a vital role in providing leadership, resources and access to care and support for patients and their families around the world. We believe supporting their work is critical to optimizing patient care and meeting the ever-growing needs of the LSD community. Having partnered with patient organizations for more than 25 years, we are delighted to offer this highly successful program once again. Learn more.